Edmonton, Canada

Xiao-Chun Le

This inventor holds 1 USPTO granted patent. Top assignee: University of Alberta. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Nucleotide Sequence Modifications by Xiao-Chun Le

Introduction

Xiao-Chun Le is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of molecular biology, particularly in the detection and quantitation of nucleotide sequence modifications. His work is crucial for advancing cancer research and therapy.

Latest Patents

Xiao-Chun Le holds a patent titled "Methods for quantitating low level modifications of nucleotide sequences." This invention provides methods for detecting and quantifying any modification of interest in nucleic acid sequences. The methods leverage nucleic acid sequence modification-specific molecules, fluorescently labeled proteins, capillary electrophoresis, and laser-induced fluorescence. These techniques are particularly useful for identifying exposure to carcinogens, conducting early risk assessments for cancer, and monitoring cancer therapy.

Career Highlights

Xiao-Chun Le is affiliated with the University of Alberta, where he continues to engage in innovative research. His work has garnered attention for its potential applications in cancer diagnostics and treatment.

Collaborations

He has collaborated with notable colleagues, including Michael Weinfeld and James Z Xing, to further enhance the impact of his research in the scientific community.

Conclusion

Xiao-Chun Le's innovative methods for quantitating nucleotide sequence modifications represent a significant advancement in molecular biology. His contributions are vital for improving cancer detection and treatment strategies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…